Keywords: novartis, files, bla, simulect, pharmaceuticals, filed, biologic

Novartis Files BLA For Simulect

Article | 20 November 1997

Novartis Pharmaceuticals has filed a Biologic License Application withthe US Food and Drug Administration for Simulect (basiliximab), its monoclonal antibody ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Basiliximab

Simulect

Go to drug listing